{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T12:50:43Z","timestamp":1784465443533,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00393-022-01313-2","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T12:07:02Z","timestamp":1673006822000},"page":"754-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of tacrolimus versus mycophenolate mofetil as induction treatment and low-dose tacrolimus as treatment for lupus nephritis: a\u00a0meta-analysis","Wirksamkeit und Sicherheit von Tacrolimus vs. Mycophenolat-Mofetil als Induktionstherapie und niedrigdosiertem Tacrolimus zur Behandlung der Lupusnephritis: eine Metaanalyse"],"prefix":"10.1007","volume":"82","author":[{"given":"Young Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwan Gyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"issue":"7","key":"1313_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/0961203315627202","volume":"25","author":"Y Lee","year":"2016","unstructured":"Lee\u00a0Y, Choi\u00a0S, Ji\u00a0J, Song\u00a0G (2016) Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus 25(7):727\u2013734","journal-title":"Lupus"},{"issue":"5","key":"1313_CR2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05780616","volume":"12","author":"S Almaani","year":"2017","unstructured":"Almaani\u00a0S, Meara\u00a0A, Rovin\u00a0BH (2017) Update on lupus nephritis. Clin J Am Soc Nephrol 12(5):825\u2013835","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1313_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4078\/jrd.2022.29.1.22","volume":"29","author":"SJ Choi","year":"2022","unstructured":"Choi\u00a0SJ, Ahn\u00a0SM, Oh\u00a0JS, Hong\u00a0S, Lee\u00a0C\u2011K, Yoo\u00a0B et al (2022) Initial preserved renal function as a\u00a0predictor of favorable renal response to rituximab in refractory or relapsing lupus nephritis: a single-center cohort study in korea. J\u00a0Rheum Dis 29(1):22\u201332","journal-title":"J Rheum Dis"},{"issue":"6","key":"1313_CR4","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/art.39594","volume":"68","author":"MG Tektonidou","year":"2016","unstructured":"Tektonidou\u00a0MG, Dasgupta\u00a0A, Ward\u00a0MM (2016) Risk of end-stage renal disease in patients with lupus nephritis, 1971\u20132015: a\u00a0systematic review and Bayesian meta-analysis. Arthritis Rheumatol 68(6):1432\u20131441","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1313_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1191\/0961203303lu1028oa","volume":"13","author":"M Petri","year":"2004","unstructured":"Petri\u00a0M (2004) Cyclophosphamide: new approaches for systemic lupus erythematosus. Lupus 13(5):366\u2013371","journal-title":"Lupus"},{"issue":"5","key":"1313_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1440-1797.2005.00444.x","volume":"10","author":"LM Ong","year":"2005","unstructured":"Ong\u00a0LM, Hooi\u00a0LS, Lim\u00a0TO, Goh\u00a0BL, Ahmad\u00a0G, Ghazalli\u00a0R et\u00a0al (2005) Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology 10(5):504\u2013510","journal-title":"Nephrology"},{"issue":"9","key":"1313_CR7","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","volume":"40","author":"T Kino","year":"1987","unstructured":"Kino\u00a0T, Hatanaka\u00a0H, Miyata\u00a0S, Inamura\u00a0N, Nishiyama\u00a0M, Yajima\u00a0T et al (1987) FK-506, a\u00a0novel immunosuppressant isolated from a\u00a0Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J\u00a0Antibiot (Tokyo) 40(9):1256\u20131265","journal-title":"J Antibiot (Tokyo)"},{"issue":"4","key":"1313_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4078\/jrd.2021.28.4.202","volume":"28","author":"W-H Yoo","year":"2021","unstructured":"Yoo\u00a0W\u2011H, Lee\u00a0S\u2011I, Kim\u00a0T\u2011H, Sung\u00a0J\u2011J, Kim\u00a0SM, Hua\u00a0F et al (2021) Safety of tacrolimus in autoimmune disease: results from post-marketing surveillance in south korea. J\u00a0Rheum Dis 28(4):202\u2013215","journal-title":"J Rheum Dis"},{"issue":"38","key":"1313_CR9","doi-asserted-by":"publisher","first-page":"e22328","DOI":"10.1097\/MD.0000000000022328","volume":"99","author":"Y-P Jiang","year":"2020","unstructured":"Jiang\u00a0Y\u2011P, Zhao\u00a0X\u2011X, Chen\u00a0R\u2011R, Xu\u00a0Z\u2011H, Wen\u00a0C\u2011P, Yu\u00a0J (2020) Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: a systematic review and meta-analysis. Medicine 99(38):e22328","journal-title":"Medicine"},{"key":"1313_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2147\/DDDT.S189156","volume":"13","author":"T Zhou","year":"2019","unstructured":"Zhou\u00a0T, Lin\u00a0S, Yang\u00a0S, Lin\u00a0W (2019) Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis. Drug Des Devel Ther 13:857","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"1313_CR11","first-page":"262","volume":"30","author":"YH Lee","year":"2012","unstructured":"Lee\u00a0YH, Lee\u00a0HS, Choi\u00a0SJ, Ji\u00a0JD, Song\u00a0GG (2012) Associations between TLR polymorphisms and systemic lupus erythematosus: a\u00a0systematic review and meta-analysis. Clin Exp Rheumatol 30(2):262\u2013265","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"1313_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3904\/kjim.2016.195","volume":"33","author":"YH Lee","year":"2018","unstructured":"Lee\u00a0YH (2018) An overview of meta-analysis for clinicians. Korean J Intern Med 33(2):277\u2013283","journal-title":"Korean J Intern Med"},{"issue":"5","key":"1313_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3904\/kjm.2019.94.5.391","volume":"94","author":"YH Lee","year":"2019","unstructured":"Lee\u00a0YH (2019) Strengths and limitations of meta-analysis. Korean J Med 94(5):391\u2013395","journal-title":"Korean J Med"},{"issue":"1","key":"1313_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad\u00a0AR, Moore\u00a0RA, Carroll\u00a0D, Jenkinson\u00a0C, Reynolds\u00a0DJ, Gavaghan\u00a0DJ et\u00a0al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1\u201312","journal-title":"Control Clin Trials"},{"key":"1313_CR15","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"G Wells","year":"2000","unstructured":"Wells\u00a0G, Shea\u00a0B, O\u2019connell\u00a0D, Peterson\u00a0J, Welch\u00a0V, Losos\u00a0M et al (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses"},{"issue":"4","key":"1313_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher\u00a0D, Liberati\u00a0A, Tetzlaff\u00a0J, Altman\u00a0DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264\u2013269","journal-title":"Ann Intern Med"},{"issue":"9085","key":"1313_CR17","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(05)63833-0","volume":"350","author":"G Davey Smith","year":"1997","unstructured":"Davey Smith\u00a0G, Egger\u00a0M (1997) Meta-analyses of randomised controlled trials. Lancet 350(9085):1182","journal-title":"Lancet"},{"issue":"11","key":"1313_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins\u00a0JP, Thompson\u00a0SG (2002) Quantifying heterogeneity in a\u00a0meta-analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"7109","key":"1313_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger\u00a0M, Davey Smith\u00a0G, Schneider\u00a0M, Minder\u00a0C (1997) Bias in meta-analysis detected by a\u00a0simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"issue":"6","key":"1313_CR20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3109\/s10165-009-0218-5","volume":"19","author":"N Miyasaka","year":"2009","unstructured":"Miyasaka\u00a0N, Kawai\u00a0S, Hashimoto\u00a0H (2009) Efficacy and safety of tacrolimus for lupus nephritis: a\u00a0placebo-controlled double-blind multicenter study. Mod Rheumatol 19(6):606\u2013615","journal-title":"Mod Rheumatol"},{"issue":"6","key":"1313_CR21","first-page":"430","volume":"72","author":"H Tanaka","year":"2009","unstructured":"Tanaka\u00a0H, Oki\u00a0E, Tsuruga\u00a0K, Yashiro\u00a0T, Hanada\u00a0I, Ito\u00a0E (2009) Management of young patients with lupus nephritis using tacrolimus administered as a\u00a0single daily dose. Clin Nephrol 72(6):430\u2013436","journal-title":"Clin Nephrol"},{"issue":"4","key":"1313_CR22","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/ndt\/gfr484","volume":"27","author":"X Li","year":"2012","unstructured":"Li\u00a0X, Ren\u00a0H, Zhang\u00a0Q, Zhang\u00a0W, Wu\u00a0X, Xu\u00a0Y et\u00a0al (2012) Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis. Nephrol Dial Transplant 27(4):1467\u20131472","journal-title":"Nephrol Dial Transplant"},{"issue":"3-4","key":"1313_CR23","doi-asserted-by":"publisher","first-page":"c165","DOI":"10.1159\/000346149","volume":"121","author":"H Tanaka","year":"2012","unstructured":"Tanaka\u00a0H, Watanabe\u00a0S, Aizawa-Yashiro\u00a0T, Oki\u00a0E, Kumagai\u00a0N, Tsuruga\u00a0K et al (2012) Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a\u00a0prospective study in daily clinical practice. Nephron Clin Pract 121(3-4):c165\u2013c73","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"1313_CR24","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1440-1797.2012.01574.x","volume":"17","author":"DY Yap","year":"2012","unstructured":"Yap\u00a0DY, Yu\u00a0X, Chen\u00a0XM, Lu\u00a0F, Chen\u00a0N, Li\u00a0XW et\u00a0al (2012) Pilot 24\u00a0month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome. Nephrology 17(4):352\u2013357","journal-title":"Nephrology"},{"issue":"1","key":"1313_CR25","first-page":"62","volume":"31","author":"Y Fei","year":"2013","unstructured":"Fei\u00a0Y, Wu\u00a0Q, Zhang\u00a0W, Chen\u00a0H, Hou\u00a0Y, Xu\u00a0D et al (2013) Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a\u00a0prospective cohort study. Clin Exp Rheumatol 31(1):62\u201368","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1313_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/annrheumdis-2014-206456","volume":"75","author":"CC Mok","year":"2016","unstructured":"Mok\u00a0CC, Ying\u00a0KY, Yim\u00a0CW, Siu\u00a0YP, Tong\u00a0KH, To\u00a0CH et al (2016) Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a\u00a0randomised controlled trial and long-term follow-up. Ann Rheum Dis 75(1):30\u201336","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1313_CR27","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1177\/0961203317739131","volume":"27","author":"N Kamanamool","year":"2018","unstructured":"Kamanamool\u00a0N, Ingsathit\u00a0A, Rattanasiri\u00a0S, Ngamjanyaporn\u00a0P, Kasitanont\u00a0N, Chawanasuntorapoj\u00a0R et\u00a0al (2018) Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a\u00a0randomized controlled trial. Lupus 27(4):647\u2013656","journal-title":"Lupus"},{"issue":"3","key":"1313_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4078\/jrd.2021.28.3.150","volume":"28","author":"J-M Shin","year":"2021","unstructured":"Shin\u00a0J\u2011M, Kim\u00a0D, Kwon\u00a0Y\u2011C, Ahn\u00a0G\u2011Y, Lee\u00a0J, Park\u00a0Y et al (2021) Clinical and genetic risk factors associated with the presence of lupus nephritis. J\u00a0Rheum Dis 28(3):150\u2013158","journal-title":"J Rheum Dis"},{"issue":"8","key":"1313_CR29","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/annrheumdis-2020-217178","volume":"79","author":"CC Mok","year":"2020","unstructured":"Mok\u00a0CC, Ho\u00a0LY, Ying\u00a0SKY, Leung\u00a0MC, To\u00a0CH, Ng\u00a0WL (2020) Long-term outcome of a\u00a0randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis. Ann Rheum Dis 79(8):1070\u20131076","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1313_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5414\/CN109325","volume":"89","author":"T-H Yang","year":"2018","unstructured":"Yang\u00a0T\u2011H, Tsai-Hung\u00a0W, Chang\u00a0Y\u2011L, Liao\u00a0H\u2011T, Chia-Chen\u00a0H, Tsai\u00a0C\u2011Y et al (2018) Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus. Clin Nephrol 89(4):277","journal-title":"Clin Nephrol"},{"issue":"1","key":"1313_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7326\/M14-1030","volume":"162","author":"Z Liu","year":"2015","unstructured":"Liu\u00a0Z, Zhang\u00a0H, Liu\u00a0Z, Xing\u00a0C, Fu\u00a0P, Ni\u00a0Z et\u00a0al (2015) Multitarget therapy for induction treatment of lupus nephritis: a\u00a0randomized trial. Ann Intern Med 162(1):18\u201326","journal-title":"Ann Intern Med"},{"issue":"12","key":"1313_CR32","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1177\/09612033221122148","volume":"31","author":"YH Lee","year":"2022","unstructured":"Lee\u00a0YH, Song\u00a0GG (2022) Multitarget therapy versus monotherapy as induction treatment for lupus nephritis: a meta-analysis of randomized controlled trials. Lupus 31(12):1468\u20131476","journal-title":"Lupus"},{"issue":"1","key":"1313_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.autrev.2015.09.006","volume":"15","author":"J Hannah","year":"2016","unstructured":"Hannah\u00a0J, Casian\u00a0A, D\u2019Cruz\u00a0D (2016) Tacrolimus use in lupus nephritis: a\u00a0systematic review and meta-analysis. Autoimmun Rev 15(1):93\u2013101","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1313_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4078\/jrd.2020.27.4.277","volume":"27","author":"YH Lee","year":"2020","unstructured":"Lee\u00a0YH, Song\u00a0GG (2020) Association between signal transducers and activators of transcription 4 rs7574865 polymorphism and systemic lupus erythematosus: a meta-analysis. J\u00a0Rheum Dis 27(4):277\u2013284","journal-title":"J Rheum Dis"},{"issue":"3","key":"1313_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4078\/jrd.2020.27.3.152","volume":"27","author":"YH Lee","year":"2020","unstructured":"Lee\u00a0YH, Song\u00a0GG (2020) Circulating interleukin-37 levels in rheumatoid arthritis and systemic lupus erythematosus and their correlations with disease activity: a meta-analysis. J\u00a0Rheum Dis 27(3):152\u2013158","journal-title":"J Rheum Dis"},{"issue":"2","key":"1313_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4078\/jrd.2020.27.2.110","volume":"27","author":"YH Lee","year":"2020","unstructured":"Lee\u00a0YH, Song\u00a0GG (2020) Circulating interleukin-18 level in systemic lupus erythematosus. J\u00a0Rheum Dis 27(2):110\u2013115","journal-title":"J Rheum Dis"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01313-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-022-01313-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01313-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T09:04:24Z","timestamp":1699261464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-022-01313-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1007\/s00393-022-01313-2","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"3 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Y.H.\u00a0Lee and G.G.\u00a0Song declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}